On September 24, Illumina rose 5.03% in regular trading, trading at 267.92 USD/share with turnover of $145 million, hitting a fresh 52-week high.

On the news front, the S&P Dow Jones Indices quarterly rebalance officially took effect on September 21, with Illumina added to the S&P 500 index, replacing Builders FirstSource. Index inclusion means that passive index funds tracking the S&P 500 globally are required to allocate the stock, and the capital inflow effect typically continues to be released over several trading days following the effective date. The stock is currently in the peak window of this passive buying wave.

Additionally, UBS recently upgraded Illumina from Neutral to Buy, significantly raising its price target from $135 to $260. This follows earlier upgrades from JPMorgan to Overweight with a $185 target, RBC Capital Markets maintaining Outperform and raising its target to $230, and Daiwa Securities upgrading to Outperform. The consensus analyst rating stands at Overweight. Fundamentally, the company reported Q2 adjusted EPS of $1.31 beating the $1.23 estimate, with revenue of $1.159 billion also exceeding the $1.130 billion consensus, while the board authorized an additional $1.5 billion stock buyback program.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)